| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/28/2023 | 11.35% | Goldman Sachs | → $26 | Initiates Coverage On | → Neutral |
| 11/21/2023 | 28.48% | Mizuho | → $30 | Initiates Coverage On | → Buy |
| 10/20/2023 | 24.2% | Exane BNP Paribas | → $29 | Initiates Coverage On | → Outperform |
| 10/17/2023 | -1.5% | Morgan Stanley | → $23 | Upgrades | Equal-Weight → Overweight |
| 10/03/2023 | -1.5% | Morgan Stanley | $26 → $23 | Maintains | Equal-Weight |
| 09/20/2023 | 11.35% | Morgan Stanley | $34 → $26 | Maintains | Equal-Weight |
| 08/18/2023 | 2.78% | Citigroup | → $24 | Initiates Coverage On | → Neutral |
| 08/15/2023 | 15.63% | B of A Securities | → $27 | Upgrades | Neutral → Buy |
| 06/23/2023 | 45.61% | Morgan Stanley | $37 → $34 | Maintains | Equal-Weight |
| 06/02/2023 | 2.78% | B of A Securities | $29 → $24 | Maintains | Neutral |
| 03/23/2023 | 45.61% | B of A Securities | $34 → $34 | Maintains | Neutral |
| 02/27/2023 | 45.61% | B of A Securities | $34 → $34 | Maintains | Neutral |
| 02/23/2023 | 75.59% | Cowen & Co. | $44 → $41 | Maintains | Outperform |
| 02/21/2023 | 105.57% | Oppenheimer | $50 → $48 | Maintains | Outperform |
| 02/17/2023 | 105.57% | Oppenheimer | $50 → $48 | Maintains | Outperform |
| 02/17/2023 | 122.7% | JP Morgan | $56 → $52 | Maintains | Overweight |
| 01/24/2023 | 45.61% | B of A Securities | $39 → $34 | Upgrades | Underperform → Neutral |
| 01/10/2023 | 58.46% | Morgan Stanley | $58 → $37 | Maintains | Equal-Weight |
| 10/31/2022 | 114.13% | Oppenheimer | $62 → $50 | Maintains | Outperform |
| 10/25/2022 | 114.13% | B. Riley Securities | $55 → $50 | Maintains | Buy |
| 10/20/2022 | 139.83% | JP Morgan | $67 → $56 | Maintains | Overweight |
| 08/18/2022 | 67.02% | B of A Securities | $34 → $39 | Maintains | Underperform |
| 08/18/2022 | 148.39% | Morgan Stanley | $55 → $58 | Maintains | Equal-Weight |
| 08/08/2022 | 186.94% | JP Morgan | $61 → $67 | Maintains | Overweight |
| 07/26/2022 | 45.61% | B of A Securities | $35 → $34 | Maintains | Underperform |
| 06/13/2022 | 135.55% | Morgan Stanley | $66 → $55 | Maintains | Equal-Weight |
| 04/22/2022 | 186.94% | B. Riley Securities | $64 → $67 | Maintains | Buy |
| 04/20/2022 | 182.66% | Morgan Stanley | $67 → $66 | Maintains | Equal-Weight |
| 03/22/2022 | 186.94% | Morgan Stanley | $66 → $67 | Maintains | Equal-Weight |
| 02/15/2022 | 114.13% | UBS | $60 → $50 | Upgrades | Neutral → Buy |
| 01/26/2022 | 41.33% | B of A Securities | $54 → $33 | Maintains | Underperform |
| 12/09/2021 | 182.66% | Morgan Stanley | $62 → $66 | Maintains | Equal-Weight |
| 11/30/2021 | 255.46% | B. Riley Securities | $82 → $83 | Maintains | Buy |
| 10/14/2021 | 178.37% | Berenberg | → $65 | Initiates Coverage On | → Buy |
| 09/21/2021 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
| 08/30/2021 | 251.18% | B. Riley Securities | $80 → $82 | Maintains | Buy |
| 08/12/2021 | 131.26% | B of A Securities | $55 → $54 | Maintains | Underperform |
| 04/29/2021 | 131.26% | B of A Securities | $63 → $54 | Downgrades | Neutral → Underperform |
| 03/10/2021 | 156.96% | Morgan Stanley | $62 → $60 | Maintains | Equal-Weight |
| 01/12/2021 | 204.07% | B of A Securities | $65 → $71 | Maintains | Neutral |
| 01/12/2021 | 165.52% | Morgan Stanley | $41 → $62 | Maintains | Equal-Weight |
| 12/09/2020 | 131.26% | B of A Securities | $49 → $54 | Maintains | Neutral |
| 11/17/2020 | 67.02% | Morgan Stanley | $38 → $39 | Maintains | Equal-Weight |
| 10/20/2020 | 62.74% | Morgan Stanley | $37 → $38 | Maintains | Equal-Weight |
| 09/18/2020 | 58.46% | Morgan Stanley | $31 → $37 | Maintains | Equal-Weight |
| 08/14/2020 | 32.76% | Morgan Stanley | $28 → $31 | Maintains | Equal-Weight |
| 08/13/2020 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 07/17/2020 | 19.91% | Morgan Stanley | $26 → $28 | Maintains | Equal-Weight |
| 06/17/2020 | 11.35% | Morgan Stanley | $28 → $26 | Maintains | Equal-Weight |
| 06/16/2020 | 71.31% | BTIG | → $40 | Initiates Coverage On | → Buy |
| 05/15/2020 | 19.91% | Morgan Stanley | $26 → $28 | Maintains | Equal-Weight |
| 05/08/2020 | 67.02% | JP Morgan | $37 → $39 | Maintains | Overweight |
| 04/15/2020 | 11.35% | Morgan Stanley | $22 → $26 | Maintains | Equal-Weight |
| 03/27/2020 | -5.78% | Morgan Stanley | $35 → $22 | Maintains | Equal-Weight |
| 03/27/2020 | 58.46% | JP Morgan | $42 → $37 | Maintains | Overweight |
| 02/21/2020 | 79.87% | B. Riley Securities | $33 → $42 | Maintains | Buy |
| 11/08/2019 | 24.2% | UBS | $27 → $29 | Maintains | Neutral |
| 11/30/2018 | -1.5% | UBS | $22 → $23 | Downgrades | Buy → Neutral |
What is the target price for Hannon Armstrong (HASI)?
The latest price target for Hannon Armstrong (NYSE: HASI) was reported by Goldman Sachs on November 28, 2023. The analyst firm set a price target for $26.00 expecting HASI to rise to within 12 months (a possible 11.35% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Hannon Armstrong (HASI)?
The latest analyst rating for Hannon Armstrong (NYSE: HASI) was provided by Goldman Sachs, and Hannon Armstrong initiated their neutral rating.
When is the next analyst rating going to be posted or updated for Hannon Armstrong (HASI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hannon Armstrong, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hannon Armstrong was filed on November 28, 2023 so you should expect the next rating to be made available sometime around November 28, 2024.
Is the Analyst Rating Hannon Armstrong (HASI) correct?
While ratings are subjective and will change, the latest Hannon Armstrong (HASI) rating was a initiated with a price target of $0.00 to $26.00. The current price Hannon Armstrong (HASI) is trading at is $23.35, which is within the analyst's predicted range.